Drug
HS 10382
HS 10382: highest development phase Phase 1, developed by Jiangsu Hansoh Pharmaceutical Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| HS-10382 NCT07933224 | Phase 1 |
Latest
No recent events.
Follow HS 10382 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.